Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02564614
Title A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Indianapolis Indiana 46202 United States Details
Laura and ISAAC Perlmutter Cancer Center at NYU Langone. New York New York 10016 United States Details
NYU Langone Medical Center; Bellevue Hospital New York New York 10016 United States Details
Weill Cornell Medical College New York New York 10021 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
Ohio State University Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field